Sorafenib Tablets 200mg
SORALIEVA contains Sorafenib, an oral multi-kinase inhibitor. It blocks multiple kinases involved in tumor cell proliferation and angiogenesis, including RAF kinases, VEGFR, and PDGFR, slowing tumor growth.
View Details
Lenvatinib Capsules 10mg
LENVALIEVA 10 mg contains Lenvatinib, an oral multi-targeted tyrosine kinase inhibitor (TKI). It blocks receptors involved in tumor angiogenesis and growth, including VEGFR 1–3, FGFR 1–4, PDGFR-α, RET, and KIT, leading to inhibition of tumor blood vessel formation and cancer cell proliferation.
View Details
Lenvatinib Capsules 4mg
LENVALIEVA 4 mg contains Lenvatinib, an oral multi-targeted tyrosine kinase inhibitor (TKI). It inhibits multiple receptors involved in tumor growth and angiogenesis, including VEGFR 1–3, FGFR 1–4, PDGFR-α, RET, and KIT, thereby suppressing tumor vascularization and proliferation.
View Details
